CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 35,926	$ 21,102
General and administrative	15,201	5,565
Total operating expenses	51,127	26,667
Loss from operations	(51,127)	(26,667)
Other (expense) income:
Interest and other (expense) income, net	(31)	144
Total other (expense) income, net	(31)	144
Net loss	$ (51,158)	$ (26,523)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (8.16)	$ (24.00)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (8.16)	$ (24.00)
Weighted-average common shares outstanding, basic (in shares)	6,267,776	1,105,260
Weighted-average common shares outstanding, diluted (in shares)	6,267,776	1,105,260